Short Interest in Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) Declines By 90.5%

Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXGGet Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 200 shares, a decrease of 90.5% from the January 15th total of 2,100 shares. Based on an average daily trading volume, of 93,600 shares, the short-interest ratio is presently 0.0 days.

Aoxing Pharmaceutical Stock Performance

Shares of Aoxing Pharmaceutical stock traded down $0.00 on Wednesday, hitting $0.01. 150,000 shares of the company traded hands, compared to its average volume of 42,209. Aoxing Pharmaceutical has a 12-month low of $0.00 and a 12-month high of $0.02. The firm’s 50-day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

About Aoxing Pharmaceutical

(Get Free Report)

Aoxing Pharmaceutical Company, Inc a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain.

Further Reading

Receive News & Ratings for Aoxing Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aoxing Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.